{"code":1,"object":{"up":[{"title":"质控医师","submitName":"CM-0-1-1-1","type":"字符串","example":"例:\"填写文字说明\"","notNull":"是","remark":"不能超过50个文字说明;</br>只允许填写中文汉字、字母、数字","hasTable":null},{"title":"质控护士","submitName":"CM-0-1-1-2","type":"字符串","example":"例:\"填写文字说明\"","notNull":"是","remark":"不能超过50个文字说明;</br>只允许填写中文汉字、字母、数字","hasTable":null},{"title":"主治医师","submitName":"CM-0-1-1-3","type":"字符串","example":"例:\"填写文字说明\"","notNull":"是","remark":"不能超过50个文字说明;</br>只允许填写中文汉字、字母、数字","hasTable":null},{"title":"责任护士","submitName":"CM-0-1-1-4","type":"字符串","example":"例:\"填写文字说明\"","notNull":"是","remark":"不能超过50个文字说明;</br>只允许填写中文汉字、字母、数字","hasTable":null},{"title":"上报科室","submitName":"CM-0-1-1-5","type":"字符串","example":"例:\"填写文字说明\"","notNull":"是","remark":"不能超过50个文字说明;</br>只允许填写中文汉字、字母、数字","hasTable":null},{"title":"患者病案号","submitName":"caseId","type":"字符串","example":"例:\"填写文字说明\"","notNull":"是","remark":"","hasTable":null},{"title":"中高风险患者和入住ICU的患者的主要风险项选择","submitName":"VTE-0-1-1","type":"字符串","example":"例:\"a\"","notNull":"是","remark":"","hasTable":"true"},{"title":"恶性肿瘤ICD-10类目编码","submitName":"VTE-0-1-1-c","type":"字符串","example":"例:\"a\"","notNull":"参考备注","remark":"中高风险患者和入住ICU的患者的主要风险项选择(VTE-0-1-1)等于\"恶性肿瘤\"(c)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"脓毒症ICD-10亚目编码","submitName":"VTE-0-1-1-d","type":"字符串","example":"例:\"d\"","notNull":"参考备注","remark":"中高风险患者和入住ICU的患者的主要风险项选择(VTE-0-1-1)等于\"脓毒症\"(d)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"累及身体多个部位损伤ICD-10类目编码","submitName":"VTE-0-1-1-e","type":"字符串","example":"例:\"a\"","notNull":"参考备注","remark":"中高风险患者和入住ICU的患者的主要风险项选择(VTE-0-1-1)等于\"严重创伤\"(e)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"制动选择","submitName":"VTE-0-1-1-i","type":"字符串","example":"例:\"a\"","notNull":"参考备注","remark":"中高风险患者和入住ICU的患者的主要风险项选择(VTE-0-1-1)等于\"制动\"(i)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"机械通气ICD-9-CM-3亚目编码","submitName":"VTE-0-1-1-j","type":"字符串","example":"例:\"a\"","notNull":"参考备注","remark":"中高风险患者和入住ICU的患者的主要风险项选择(VTE-0-1-1)等于\"机械通气\"(j)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"留置中心静脉导管ICD-9-CM-3亚目编码","submitName":"VTE-0-1-1-k","type":"字符串","example":"例:\"a\"","notNull":"参考备注","remark":"中高风险患者和入住ICU的患者的主要风险项选择(VTE-0-1-1)等于\"留置中心静脉导管\"(k)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"血液净化治疗ICD-9-CM-3亚目编码","submitName":"VTE-0-1-1-l","type":"字符串","example":"例:\"a\"","notNull":"参考备注","remark":"中高风险患者和入住ICU的患者的主要风险项选择(VTE-0-1-1)等于\"血液净化治疗\"(l)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"使用肌肉松弛和镇静药物选择","submitName":"VTE-0-1-1-m","type":"字符串","example":"例:\"a\"","notNull":"参考备注","remark":"中高风险患者和入住ICU的患者的主要风险项选择(VTE-0-1-1)等于\"使用肌肉松弛和镇静药物\"(m)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"应用收缩血管药物选择","submitName":"VTE-0-1-1-n","type":"字符串","example":"例:\"a\"","notNull":"参考备注","remark":"中高风险患者和入住ICU的患者的主要风险项选择(VTE-0-1-1)等于\"应用收缩血管药物\"(n)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"医师认为需评估的其他中高风险患者--高危孕产妇记录","submitName":"VTE-0-1-1-q","type":"字符串","example":"例:\"a\"","notNull":"参考备注","remark":"中高风险患者和入住ICU的患者的主要风险项选择(VTE-0-1-1)等于\"医师认为需评估的其他中高风险患者--高危孕产妇\"(q)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"出院时主要诊断ICD-10编码及名称","submitName":"VTE-0-1-3","type":"字符串","example":"例:\"填写文字说明\"","notNull":"是","remark":"文本长度不能超过30个字说明","hasTable":null},{"title":"出院时其他诊断ICD-10编码及名称","submitName":"VTE-0-1-4","type":"字符串","example":"例:\"填写文字说明\"","notNull":"否","remark":"若该字段无相应取值，则接口中不必提交该字段</br>文本长度不能超过30个字说明","hasTable":null},{"title":"出院时主要手术及操作ICD-9-CM-3编码及名称","submitName":"VTE-0-1-5","type":"字符串","example":"例:\"填写文字说明\"","notNull":"否","remark":"若该字段无相应取值，则接口中不必提交该字段</br>文本长度不能超过30个字说明","hasTable":null},{"title":"出院时其他手术及操作ICD-9-CM-3编码及名称","submitName":"VTE-0-1-6","type":"字符串","example":"例:\"填写文字说明\"","notNull":"否","remark":"若该字段无相应取值，则接口中不必提交该字段</br>文本长度不能超过30个字说明","hasTable":null},{"title":"是否出院后31天内重复住院","submitName":"CM-0-1-5","type":"字符串","example":"例:\"y\"","notNull":"是","remark":"","hasTable":"true"},{"title":"出生日期","submitName":"CM-0-2-1-1","type":"字符串","example":"例:\"1970-01-01\"","notNull":"是","remark":"","hasTable":null},{"title":"患者性别","submitName":"CM-0-2-1-2","type":"字符串","example":"例:\"M\"","notNull":"是","remark":"","hasTable":"true"},{"title":"患者体重（kg）","submitName":"CM-0-2-1-3","type":"数值","example":"例:10","notNull":"是","remark":"患者体重填写范围(1~200);</br>患者体重填写范围(1~200)","hasTable":null},{"title":"患者身高（cm）","submitName":"CM-0-2-1-5","type":"数值","example":"例:10","notNull":"是","remark":"患者身高填写范围(1~200);</br>患者身高填写范围(1~200)","hasTable":null},{"title":"入院日期时间","submitName":"CM-0-2-4-1","type":"字符串","example":"例:\"1970-01-01 12:00\"","notNull":"是","remark":"","hasTable":null},{"title":"出院日期时间","submitName":"CM-0-2-4-2","type":"字符串","example":"例:\"1970-01-01 12:00\"","notNull":"是","remark":"出院日期时间应大于入院日期时间;</br>住院时间应大于24小时;</br>住院时间应应小于90天","hasTable":null},{"title":"入住ICU日期时间","submitName":"CM-0-2-5-1","type":"字符串","example":"例:\"1970-01-01 12:00\"","notNull":"否","remark":"若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":null},{"title":"离开ICU日期时间","submitName":"CM-0-2-5-2","type":"字符串","example":"例:\"1970-01-01 12:00\"","notNull":"否","remark":"若该字段无相应取值，则接口中不必提交该字段</br>离开ICU日期时间应大于入住ICU日期时间","hasTable":null},{"title":"手术开始（切皮）日期时间 ","submitName":"CM-0-2-6-1","type":"字符串","example":"例:\"1970-01-01 12:00\"","notNull":"否","remark":"若该字段无相应取值，则接口中不必提交该字段</br>手术开始日期时间应大于入院日期时间","hasTable":null},{"title":"手术结束（缝皮结束）日期时间","submitName":"CM-0-2-6-2","type":"字符串","example":"例:\"1970-01-01 12:00\"","notNull":"否","remark":"若该字段无相应取值，则接口中不必提交该字段</br>手术结束日期时间应大于手术开始日期时间;</br>手术结束日期时间应小于出院日期时间","hasTable":null},{"title":"费用支付方式","submitName":"CM-0-3-1","type":"字符串","example":"例:\"a\"","notNull":"是","remark":"","hasTable":"true"},{"title":"收入住院途径","submitName":"CM-0-3-2","type":"字符串","example":"例:\"a\"","notNull":"是","remark":"","hasTable":"true"},{"title":"到院交通工具","submitName":"CM-0-3-3","type":"字符串","example":"例:\"a\"","notNull":"是","remark":"","hasTable":"true"},{"title":"实施血栓风险因素评估工具选择","submitName":"VTE-1-1-1","type":"字符串","example":"例:\"a\"","notNull":"是","remark":"","hasTable":"true"},{"title":"Caprini评估分值","submitName":"VTE-1-1-2","type":"数值","example":"例:10","notNull":"参考备注","remark":"实施血栓风险因素评估工具选择(VTE-1-1-1)等于\"手术患者静脉血栓栓塞症风险评估表（Caprini评分表）\"(a)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>Caprini评估分值填写值应大于等于0","hasTable":null},{"title":"风险分层","submitName":"VTE-1-1-3","type":"字符串","example":"例:\"a\"","notNull":"否","remark":"实施血栓风险因素评估工具选择(VTE-1-1-1)等于\"手术患者静脉血栓栓塞症风险评估表（Caprini评分表）\"(a)时可填写;</br>","hasTable":"true"},{"title":"Padua评分分值","submitName":"VTE-1-1-4","type":"数值","example":"例:10","notNull":"参考备注","remark":"实施血栓风险因素评估工具选择(VTE-1-1-1)等于\"内科住院患者静脉血栓栓塞症风险评估表（Padua评分表）\"(b)时可填写;</br>若该字段无相应取值，则接口中不必提交该字段</br>Padua评分分值填写值应大于等于0","hasTable":null},{"title":"风险分层","submitName":"VTE-1-1-5","type":"字符串","example":"例:\"a\"","notNull":"否","remark":"实施血栓风险因素评估工具选择(VTE-1-1-1)等于\"内科住院患者静脉血栓栓塞症风险评估表（Padua评分表）\"(b)时可填写;</br>","hasTable":"true"},{"title":"呼吸(次/分)","submitName":"VTE-1-2-1","type":"数值","example":"例:10","notNull":"是","remark":"呼吸填写值范围(10~40);</br>呼吸填写值范围(10~40)","hasTable":null},{"title":"脉搏(次/分)","submitName":"VTE-1-2-2","type":"数值","example":"例:10","notNull":"是","remark":"脉搏填写值范围(30~200);</br>脉搏填写值范围(30~200)","hasTable":null},{"title":"收缩压(mmHg)","submitName":"VTE-1-2-3","type":"数值","example":"例:10","notNull":"是","remark":"收缩压填写值范围(40~300);</br>收缩压填写值范围(40~300)","hasTable":null},{"title":"舒张压(mmHg)","submitName":"VTE-1-2-4","type":"数值","example":"例:10","notNull":"是","remark":"舒张压填写值范围(30~200);</br>舒张压填写值范围(30~200)","hasTable":null},{"title":"实施实施下肢静脉血管多普勒超声检查评估","submitName":"VTE-2-1-1","type":"字符串","example":"例:\"y\"","notNull":"是","remark":"","hasTable":"true"},{"title":"实施多普勒超声检查评估日期时间","submitName":"VTE-2-1-2","type":"字符串","example":"例:\"1970-01-01 12:00\"","notNull":"参考备注","remark":"实施实施下肢静脉血管多普勒超声检查评估(VTE-2-1-1)等于\"实施\"(y)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>实施多普勒超声检查评估日期时间应小于出院日期时间","hasTable":null},{"title":"有无多普勒超声检查阳性发现","submitName":"VTE-2-1-3","type":"字符串","example":"例:\"y\"","notNull":"参考备注","remark":"实施实施下肢静脉血管多普勒超声检查评估(VTE-2-1-1)等于\"实施\"(y)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"实施D⁃二聚体检测评估","submitName":"VTE-2-2-1","type":"字符串","example":"例:\"y\"","notNull":"是","remark":"","hasTable":"true"},{"title":"D⁃二聚体检测评估日期时间","submitName":"VTE-2-2-2","type":"字符串","example":"例:\"1970-01-01 12:00\"","notNull":"参考备注","remark":"实施D⁃二聚体检测评估(VTE-2-2-1)等于\"实施\"(y)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>D⁃二聚体检测评估日期时间应小于出院日期时间","hasTable":null},{"title":"D⁃二聚体检测值(μg／L)","submitName":"VTE-2-2-3","type":"数值","example":"例:10","notNull":"参考备注","remark":"实施D⁃二聚体检测评估(VTE-2-2-1)等于\"实施\"(y)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>D⁃二聚体检测值应大于等于0","hasTable":null},{"title":"D⁃二聚体检测评估结论","submitName":"VTE-2-2-4","type":"字符串","example":"例:\"a\"","notNull":"参考备注","remark":"实施D⁃二聚体检测评估(VTE-2-2-1)等于\"实施\"(y)时可填写;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"是否实施氧合评估","submitName":"VTE-2-2-5","type":"字符串","example":"例:\"y\"","notNull":"参考备注","remark":"实施D⁃二聚体检测评估(VTE-2-2-1)等于\"实施\"(y)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"氧合评估","submitName":"VTE-2-2-6","type":"字符串","example":"例:\"a\"","notNull":"参考备注","remark":"是否实施氧合评估(VTE-2-2-5)等于\"是\"(y)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"动脉血气分析值(mmHg)","submitName":"VTE-2-2-6-1","type":"数值","example":"例:10","notNull":"参考备注","remark":"氧合评估(VTE-2-2-6)等于\"动脉血气分析（PaO₂）\"(a)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>动脉血气分析值填写范围(0~150);</br>动脉血气分析值填写范围(0~150)","hasTable":null},{"title":"指氧仪检查值(%)","submitName":"VTE-2-2-6-2","type":"数值","example":"例:10","notNull":"参考备注","remark":"氧合评估(VTE-2-2-6)等于\"指氧仪检查（SatO₂）\"(b)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>指氧仪检查值填写范围(0~100);</br>指氧仪检查值填写范围(0~100)","hasTable":null},{"title":"是否实施心脏生物学标志物检测","submitName":"VTE-2-2-7","type":"字符串","example":"例:\"y\"","notNull":"参考备注","remark":"实施D⁃二聚体检测评估(VTE-2-2-1)等于\"实施\"(y)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"心脏生物学标志物检测项目","submitName":"VTE-2-2-8","type":"数组","example":"例:[\"a\",\"b\"]","notNull":"参考备注","remark":"是否实施心脏生物学标志物检测(VTE-2-2-7)等于\"实施\"(y)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"肌钙蛋白T（TnT）检测值","submitName":"VTE-2-2-8-1","type":"数值","example":"例:10","notNull":"参考备注","remark":"心脏生物学标志物检测项目(VTE-2-2-8)等于\"肌钙蛋白T（TnT）\"(a)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>肌钙蛋白T（TnT）检测值填写范围应大于等于0","hasTable":null},{"title":"肌钙蛋白I（TnI）检测值","submitName":"VTE-2-2-8-2","type":"数值","example":"例:10","notNull":"参考备注","remark":"心脏生物学标志物检测项目(VTE-2-2-8)等于\"肌钙蛋白I（TnI）\"(b)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>肌钙蛋白I（TnI）检测值填写范围应大于等于0","hasTable":null},{"title":"肌酸激酶同工酶（CK-MB）检测值","submitName":"VTE-2-2-8-3","type":"数值","example":"例:10","notNull":"参考备注","remark":"心脏生物学标志物检测项目(VTE-2-2-8)等于\"肌酸激酶同工酶（CK-MB）\"(c)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>肌酸激酶同工酶（CK-MB）检测值填写范围应大于等于0","hasTable":null},{"title":"心肌肌红蛋白（Myo）检测值","submitName":"VTE-2-2-8-4","type":"数值","example":"例:10","notNull":"参考备注","remark":"心脏生物学标志物检测项目(VTE-2-2-8)等于\"心肌肌红蛋白（Myo）\"(d)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>心肌肌红蛋白（Myo）检测值填写范围应大于等于0","hasTable":null},{"title":"B型钠尿肽（BNP）检测值","submitName":"VTE-2-2-8-5","type":"数值","example":"例:10","notNull":"参考备注","remark":"心脏生物学标志物检测项目(VTE-2-2-8)等于\"B型钠尿肽（BNP）\"(e)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>B型钠尿肽（BNP）检测值填写范围应大于等于0","hasTable":null},{"title":"N端B型钠尿肽前体（NT-ProBNP）检测值","submitName":"VTE-2-2-8-6","type":"数值","example":"例:10","notNull":"参考备注","remark":"心脏生物学标志物检测项目(VTE-2-2-8)等于\"N端B型钠尿肽前体（NT-ProBNP）\"(f)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>N端B型钠尿肽前体（NT-ProBNP）检测值填写范围应大于等于0","hasTable":null},{"title":"是否实施凝血功能检测","submitName":"VTE-2-2-9","type":"字符串","example":"例:\"y\"","notNull":"参考备注","remark":"实施D⁃二聚体检测评估(VTE-2-2-1)等于\"实施\"(y)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"凝血功能检测项目","submitName":"VTE-2-2-10","type":"数组","example":"例:[\"a\",\"b\"]","notNull":"参考备注","remark":"是否实施凝血功能检测(VTE-2-2-9)等于\"实施\"(y)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"血浆凝血酶原时间（PT）检测值","submitName":"VTE-2-2-10-1","type":"数值","example":"例:10","notNull":"参考备注","remark":"凝血功能检测项目(VTE-2-2-10)等于\"血浆凝血酶原时间（PT）\"(a)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>血浆凝血酶原时间（PT）检测值填写范围应大于等于0","hasTable":null},{"title":"纤维蛋白原（FIB）检测值","submitName":"VTE-2-2-10-2","type":"数值","example":"例:10","notNull":"参考备注","remark":"凝血功能检测项目(VTE-2-2-10)等于\"纤维蛋白原（FIB）\"(b)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>纤维蛋白原（FIB）检测值填写范围应大于等于0","hasTable":null},{"title":"活化部分凝血活酶时间（APTT）检测值","submitName":"VTE-2-2-10-3","type":"数值","example":"例:10","notNull":"参考备注","remark":"凝血功能检测项目(VTE-2-2-10)等于\"活化部分凝血活酶时间（APTT）\"(c)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>活化部分凝血活酶时间（APTT）检测值填写范围应大于等于0","hasTable":null},{"title":"血浆凝血酶时间（TT）检测值","submitName":"VTE-2-2-10-4","type":"数值","example":"例:10","notNull":"参考备注","remark":"凝血功能检测项目(VTE-2-2-10)等于\"血浆凝血酶时间（TT）\"(d)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>血浆凝血酶时间（TT）检测值填写范围应大于等于0","hasTable":null},{"title":"是否行CT肺动脉造影（CTPA）检查评估","submitName":"VTE-2-3-1","type":"字符串","example":"例:\"y\"","notNull":"是","remark":"","hasTable":"true"},{"title":"实施行CT肺动脉造影（CTPA）检查日期时间","submitName":"VTE-2-3-2","type":"字符串","example":"例:\"1970-01-01 12:00\"","notNull":"参考备注","remark":"是否行CT肺动脉造影（CTPA）检查评估(VTE-2-3-1)等于\"实施\"(y)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>实施行CT肺动脉造影（CTPA）检查日期时间应小于出院日期时间","hasTable":null},{"title":"CT肺动脉造影（CTPA）检查阳性发现","submitName":"VTE-2-3-3","type":"字符串","example":"例:\"y\"","notNull":"参考备注","remark":"是否行CT肺动脉造影（CTPA）检查评估(VTE-2-3-1)等于\"实施\"(y)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"有无履行VTE预防相关的患者/家属知情同意","submitName":"VTE-3-1-1","type":"字符串","example":"例:\"y\"","notNull":"是","remark":"","hasTable":"true"},{"title":"VTE预防相关的患者/家属知情同意","submitName":"VTE-3-1-2","type":"数组","example":"例:[\"a\",\"b\"]","notNull":"参考备注","remark":"有无履行VTE预防相关的患者/家属知情同意(VTE-3-1-1)等于\"是\"(y)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"有无实施出血风险和其他可能影响预防的因素评估","submitName":"VTE-3-2-1","type":"字符串","example":"例:\"y\"","notNull":"是","remark":"","hasTable":"true"},{"title":"实施出血风险和其他可能影响预防的因素评估","submitName":"VTE-3-2-2","type":"数组","example":"例:[\"a\",\"b\"]","notNull":"参考备注","remark":"有无实施出血风险和其他可能影响预防的因素评估(VTE-3-2-1)等于\"是，有禁忌\"(y)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"患者因素选择","submitName":"VTE-3-2-2-1","type":"数组","example":"例:[\"a\",\"b\"]","notNull":"参考备注","remark":"实施出血风险和其他可能影响预防的因素评估(VTE-3-2-2)等于\"患者因素\"(a)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"基础疾病","submitName":"VTE-3-2-2-2","type":"数组","example":"例:[\"a\",\"b\"]","notNull":"参考备注","remark":"实施出血风险和其他可能影响预防的因素评估(VTE-3-2-2)等于\"基础疾病\"(b)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"合并用药","submitName":"VTE-3-2-2-3","type":"数组","example":"例:[\"a\"]","notNull":"参考备注","remark":"实施出血风险和其他可能影响预防的因素评估(VTE-3-2-2)等于\"合并用药\"(c)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"侵入性操作","submitName":"VTE-3-2-2-4","type":"数组","example":"例:[\"a\",\"b\"]","notNull":"参考备注","remark":"实施出血风险和其他可能影响预防的因素评估(VTE-3-2-2)等于\"侵入性操作\"(d)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"其他实施出血风险和其他可能影响预防的因素评估","submitName":"VTE-3-2-2-5","type":"字符串","example":"例:\"填写文字说明\"","notNull":"参考备注","remark":"实施出血风险和其他可能影响预防的因素评估(VTE-3-2-2)等于\"其他\"(oth)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":null},{"title":"物理性预防措施应用禁忌","submitName":"VTE-3-2-3","type":"数组","example":"例:[\"a\",\"b\"]","notNull":"参考备注","remark":"有无实施出血风险和其他可能影响预防的因素评估(VTE-3-2-1)等于\"是，有禁忌\"(y)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"是否需要三级预防深静脉栓塞","submitName":"VTE-3-3-0","type":"字符串","example":"例:\"y\"","notNull":"是","remark":"","hasTable":"true"},{"title":"三级预防深静脉栓塞措施选择","submitName":"VTE-3-3-1","type":"数组","example":"例:[\"a\",\"b\"]","notNull":"参考备注","remark":"是否需要三级预防深静脉栓塞(VTE-3-3-0)等于\"是\"(y)时必填;</br>是否需要三级预防深静脉栓塞(VTE-3-3-0)等于\"否\"(n)时无需填写;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"基本预防措施的选择","submitName":"VTE-3-3-2","type":"数组","example":"例:[\"a\",\"b\"]","notNull":"参考备注","remark":"是否需要三级预防深静脉栓塞(VTE-3-3-0)等于\"否\"(n)时无需填写;</br>三级预防深静脉栓塞措施选择(VTE-3-3-1)等于\"基本预防\"(a)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"其他基本预防措施","submitName":"VTE-3-3-2-1","type":"字符串","example":"例:\"填写文字说明\"","notNull":"参考备注","remark":"是否需要三级预防深静脉栓塞(VTE-3-3-0)等于\"否\"(n)时无需填写;</br>基本预防措施的选择(VTE-3-3-2)等于\"其他\"(oth)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":null},{"title":"医嘱执行起始日期","submitName":"VTE-3-3-3","type":"字符串","example":"例:\"1970-01-01 12:00\"","notNull":"参考备注","remark":"是否需要三级预防深静脉栓塞(VTE-3-3-0)等于\"否\"(n)时无需填写;</br>三级预防深静脉栓塞措施选择(VTE-3-3-1)等于\"基本预防\"(a)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>医嘱执行起始日期应小于出院日期时间","hasTable":null},{"title":"机械预防措施的选择","submitName":"VTE-3-3-4","type":"数组","example":"例:[\"a\",\"b\"]","notNull":"参考备注","remark":"是否需要三级预防深静脉栓塞(VTE-3-3-0)等于\"否\"(n)时无需填写;</br>三级预防深静脉栓塞措施选择(VTE-3-3-1)等于\"机械预防\"(b)时必填;</br>三级预防深静脉栓塞措施选择(VTE-3-3-1)等于\"药物预防+机械预防\"(d)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"其他机械预防措施","submitName":"VTE-3-3-4-1","type":"字符串","example":"例:\"填写文字说明\"","notNull":"参考备注","remark":"是否需要三级预防深静脉栓塞(VTE-3-3-0)等于\"否\"(n)时无需填写;</br>机械预防措施的选择(VTE-3-3-4)等于\"其他\"(oth)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":null},{"title":"医嘱执行日期","submitName":"VTE-3-3-5","type":"字符串","example":"例:\"1970-01-01 12:00\"","notNull":"参考备注","remark":"是否需要三级预防深静脉栓塞(VTE-3-3-0)等于\"否\"(n)时无需填写;</br>三级预防深静脉栓塞措施选择(VTE-3-3-1)等于\"机械预防\"(b)时必填;</br>三级预防深静脉栓塞措施选择(VTE-3-3-1)等于\"药物预防+机械预防\"(d)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>医嘱执行起始日期应小于出院日期时间","hasTable":null},{"title":"预防性地药物的选择","submitName":"VTE-3-3-6","type":"数组","example":"例:[\"a\",\"b\"]","notNull":"参考备注","remark":"是否需要三级预防深静脉栓塞(VTE-3-3-0)等于\"否\"(n)时无需填写;</br>三级预防深静脉栓塞措施选择(VTE-3-3-1)等于\"药物预防\"(c)时必填;</br>三级预防深静脉栓塞措施选择(VTE-3-3-1)等于\"药物预防+机械预防\"(d)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"其他预防性地药物","submitName":"VTE-3-3-6-1","type":"字符串","example":"例:\"填写文字说明\"","notNull":"参考备注","remark":"是否需要三级预防深静脉栓塞(VTE-3-3-0)等于\"否\"(n)时无需填写;</br>预防性地药物的选择(VTE-3-3-6)等于\"其他\"(oth)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":null},{"title":"医嘱执行日期","submitName":"VTE-3-2-7","type":"字符串","example":"例:\"1970-01-01 12:00\"","notNull":"参考备注","remark":"是否需要三级预防深静脉栓塞(VTE-3-3-0)等于\"否\"(n)时无需填写;</br>三级预防深静脉栓塞措施选择(VTE-3-3-1)等于\"药物预防\"(c)时必填;</br>三级预防深静脉栓塞措施选择(VTE-3-3-1)等于\"药物预防+机械预防\"(d)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>医嘱执行起始日期应小于出院日期时间","hasTable":null},{"title":"出院后继续使用抗凝药","submitName":"VTE-3-3-8","type":"字符串","example":"例:\"a\"","notNull":"参考备注","remark":"是否需要三级预防深静脉栓塞(VTE-3-3-0)等于\"否\"(n)时无需填写;</br>三级预防深静脉栓塞措施选择(VTE-3-3-1)等于\"药物预防\"(c)时可填写;</br>三级预防深静脉栓塞措施选择(VTE-3-3-1)等于\"药物预防+机械预防\"(d)时可填写;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"其他出院后继续使用抗凝药","submitName":"VTE-3-3-8-1","type":"字符串","example":"例:\"填写文字说明\"","notNull":"参考备注","remark":"是否需要三级预防深静脉栓塞(VTE-3-3-0)等于\"否\"(n)时无需填写;</br>出院后继续使用抗凝药(VTE-3-3-8)等于\"其他\"(oth)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":null},{"title":"预防依从性评估","submitName":"VTE-3-4-1","type":"字符串","example":"例:\"a\"","notNull":"参考备注","remark":"是否需要三级预防深静脉栓塞(VTE-3-3-0)等于\"是\"(y)时必填;</br>是否需要三级预防深静脉栓塞(VTE-3-3-0)等于\"否\"(n)时无需填写;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"预防安全性主要监测项目","submitName":"VTE-3-4-2","type":"数组","example":"例:[\"a\",\"b\"]","notNull":"参考备注","remark":"是否需要三级预防深静脉栓塞(VTE-3-3-0)等于\"是\"(y)时必填;</br>是否需要三级预防深静脉栓塞(VTE-3-3-0)等于\"否\"(n)时无需填写;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"其他预防安全性主要监测项目","submitName":"VTE-3-4-2-1","type":"字符串","example":"例:\"填写文字说明\"","notNull":"参考备注","remark":"是否需要三级预防深静脉栓塞(VTE-3-3-0)等于\"否\"(n)时无需填写;</br>预防安全性主要监测项目(VTE-3-4-2)等于\"其他\"(oth)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>文本长度不能超过20个字说明","hasTable":null},{"title":"是否进行预防效果评估","submitName":"VTE-3-4-3","type":"字符串","example":"例:\"y\"","notNull":"参考备注","remark":"是否需要三级预防深静脉栓塞(VTE-3-3-0)等于\"是\"(y)时必填;</br>是否需要三级预防深静脉栓塞(VTE-3-3-0)等于\"否\"(n)时无需填写;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"预防效果评估及相关不良事件","submitName":"VTE-3-4-4","type":"数组","example":"例:[\"a\",\"b\"]","notNull":"参考备注","remark":"是否需要三级预防深静脉栓塞(VTE-3-3-0)等于\"否\"(n)时无需填写;</br>是否进行预防效果评估(VTE-3-4-3)等于\"是\"(y)时必填;</br>是否进行预防效果评估(VTE-3-4-3)等于\"否\"(n)时无需填写;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"与预防相关的不良事件","submitName":"VTE-3-4-4-1","type":"字符串","example":"例:\"填写文字说明\"","notNull":"参考备注","remark":"是否需要三级预防深静脉栓塞(VTE-3-3-0)等于\"否\"(n)时无需填写;</br>是否进行预防效果评估(VTE-3-4-3)等于\"否\"(n)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"与预防相关的不良事件\"(d)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>文本长度不能超过20个字说明","hasTable":null},{"title":"与预防不相关的不良事件","submitName":"VTE-3-4-4-2","type":"字符串","example":"例:\"填写文字说明\"","notNull":"参考备注","remark":"是否需要三级预防深静脉栓塞(VTE-3-3-0)等于\"否\"(n)时无需填写;</br>是否进行预防效果评估(VTE-3-4-3)等于\"否\"(n)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"与预防不相关的不良事件\"(e)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>文本长度不能超过20个字说明","hasTable":null},{"title":"其他预防效果评估及相关不良事件","submitName":"VTE-3-4-4-3","type":"字符串","example":"例:\"填写文字说明\"","notNull":"参考备注","remark":"是否需要三级预防深静脉栓塞(VTE-3-3-0)等于\"否\"(n)时无需填写;</br>是否进行预防效果评估(VTE-3-4-3)等于\"否\"(n)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"其他\"(oth)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>文本长度不能超过20个字说明","hasTable":null},{"title":"是否为临床高度拟诊\"VTE\"的患者","submitName":"VTE-4-1-1","type":"字符串","example":"例:\"a\"","notNull":"参考备注","remark":"是否需要三级预防深静脉栓塞(VTE-3-3-0)等于\"否\"(n)时无需填写;</br>是否进行预防效果评估(VTE-3-4-3)等于\"否\"(n)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"无症状性VTE的发生\"(a)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"与预防相关的不良事件\"(d)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"与预防不相关的不良事件\"(e)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"其他\"(oth)时无需填写;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"DVT临床高度可疑患者的识别检查项目","submitName":"VTE-4-1-2","type":"数组","example":"例:[\"a\",\"b\"]","notNull":"参考备注","remark":"是否需要三级预防深静脉栓塞(VTE-3-3-0)等于\"否\"(n)时无需填写;</br>是否进行预防效果评估(VTE-3-4-3)等于\"否\"(n)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"无症状性VTE的发生\"(a)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"与预防相关的不良事件\"(d)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"与预防不相关的不良事件\"(e)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"其他\"(oth)时无需填写;</br>是否为临床高度拟诊\"VTE\"的患者(VTE-4-1-1)等于\"DVT临床高度可疑患者\"(a)时必填;</br>是否为临床高度拟诊\"VTE\"的患者(VTE-4-1-1)等于\"非临床高度拟诊\"VTE\"的患者\"(c)时无需填写;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"其他DVT临床高度可疑患者的识别检查项目","submitName":"VTE-4-1-2-1","type":"字符串","example":"例:\"填写文字说明\"","notNull":"参考备注","remark":"是否需要三级预防深静脉栓塞(VTE-3-3-0)等于\"否\"(n)时无需填写;</br>是否进行预防效果评估(VTE-3-4-3)等于\"否\"(n)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"无症状性VTE的发生\"(a)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"与预防相关的不良事件\"(d)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"与预防不相关的不良事件\"(e)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"其他\"(oth)时无需填写;</br>是否为临床高度拟诊\"VTE\"的患者(VTE-4-1-1)等于\"非临床高度拟诊\"VTE\"的患者\"(c)时无需填写;</br>DVT临床高度可疑患者的识别检查项目(VTE-4-1-2)等于\"其他识别方法\"(oth)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>文本长度不能超过10个字说明","hasTable":null},{"title":"急性PTE临床高度可疑患者的识别检查项目","submitName":"VTE-4-1-3","type":"数组","example":"例:[\"a\",\"b\"]","notNull":"参考备注","remark":"是否需要三级预防深静脉栓塞(VTE-3-3-0)等于\"否\"(n)时无需填写;</br>是否进行预防效果评估(VTE-3-4-3)等于\"否\"(n)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"无症状性VTE的发生\"(a)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"与预防相关的不良事件\"(d)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"与预防不相关的不良事件\"(e)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"其他\"(oth)时无需填写;</br>是否为临床高度拟诊\"VTE\"的患者(VTE-4-1-1)等于\"急性PTE临床高度可疑患者\"(b)时必填;</br>是否为临床高度拟诊\"VTE\"的患者(VTE-4-1-1)等于\"非临床高度拟诊\"VTE\"的患者\"(c)时无需填写;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"其他急性PTE临床高度可疑患者的识别检查项目","submitName":"VTE-4-1-3-1","type":"字符串","example":"例:\"填写文字说明\"","notNull":"参考备注","remark":"是否需要三级预防深静脉栓塞(VTE-3-3-0)等于\"否\"(n)时无需填写;</br>是否进行预防效果评估(VTE-3-4-3)等于\"否\"(n)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"无症状性VTE的发生\"(a)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"与预防相关的不良事件\"(d)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"与预防不相关的不良事件\"(e)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"其他\"(oth)时无需填写;</br>是否为临床高度拟诊\"VTE\"的患者(VTE-4-1-1)等于\"非临床高度拟诊\"VTE\"的患者\"(c)时无需填写;</br>急性PTE临床高度可疑患者的识别检查项目(VTE-4-1-3)等于\"其他识别方法\"(oth)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>文本长度不能超过10个字说明","hasTable":null},{"title":"出现首个VTE的临床表现时间","submitName":"VTE-4-1-4","type":"字符串","example":"例:\"1970-01-01 12:00\"","notNull":"参考备注","remark":"是否需要三级预防深静脉栓塞(VTE-3-3-0)等于\"否\"(n)时无需填写;</br>是否进行预防效果评估(VTE-3-4-3)等于\"否\"(n)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"无症状性VTE的发生\"(a)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"与预防相关的不良事件\"(d)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"与预防不相关的不良事件\"(e)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"其他\"(oth)时无需填写;</br>是否为临床高度拟诊\"VTE\"的患者(VTE-4-1-1)等于\"非临床高度拟诊\"VTE\"的患者\"(c)时无需填写;</br>若该字段无相应取值，则接口中不必提交该字段</br>出现首个VTE的临床表现时间应小于出院日期时间","hasTable":null},{"title":"是否经MDT制定VTE 针对性紧急处理方案","submitName":"VTE-4-2-1","type":"字符串","example":"例:\"y\"","notNull":"参考备注","remark":"是否需要三级预防深静脉栓塞(VTE-3-3-0)等于\"否\"(n)时无需填写;</br>是否进行预防效果评估(VTE-3-4-3)等于\"否\"(n)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"无症状性VTE的发生\"(a)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"与预防相关的不良事件\"(d)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"与预防不相关的不良事件\"(e)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"其他\"(oth)时无需填写;</br>是否为临床高度拟诊\"VTE\"的患者(VTE-4-1-1)等于\"非临床高度拟诊\"VTE\"的患者\"(c)时无需填写;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"临床高度可疑为VTE后,针对性紧急处理的方法","submitName":"VTE-4-2-2","type":"数组","example":"例:[\"a\",\"b\"]","notNull":"参考备注","remark":"是否需要三级预防深静脉栓塞(VTE-3-3-0)等于\"否\"(n)时无需填写;</br>是否进行预防效果评估(VTE-3-4-3)等于\"否\"(n)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"无症状性VTE的发生\"(a)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"与预防相关的不良事件\"(d)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"与预防不相关的不良事件\"(e)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"其他\"(oth)时无需填写;</br>是否为临床高度拟诊\"VTE\"的患者(VTE-4-1-1)等于\"非临床高度拟诊\"VTE\"的患者\"(c)时无需填写;</br>是否经MDT制定VTE 针对性紧急处理方案(VTE-4-2-1)等于\"是\"(y)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"其他临床高度可疑为VTE后,针对性紧急处理的方法","submitName":"VTE-4-2-2-1","type":"字符串","example":"例:\"填写文字说明\"","notNull":"参考备注","remark":"是否需要三级预防深静脉栓塞(VTE-3-3-0)等于\"否\"(n)时无需填写;</br>是否进行预防效果评估(VTE-3-4-3)等于\"否\"(n)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"无症状性VTE的发生\"(a)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"与预防相关的不良事件\"(d)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"与预防不相关的不良事件\"(e)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"其他\"(oth)时无需填写;</br>是否为临床高度拟诊\"VTE\"的患者(VTE-4-1-1)等于\"非临床高度拟诊\"VTE\"的患者\"(c)时无需填写;</br>临床高度可疑为VTE后,针对性紧急处理的方法(VTE-4-2-2)等于\"其他\"(oth)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":null},{"title":"抗凝重叠治疗医嘱的执行起始的时间选择","submitName":"VTE-4-5-1","type":"数组","example":"例:[\"a\",\"b\"]","notNull":"参考备注","remark":"是否需要三级预防深静脉栓塞(VTE-3-3-0)等于\"否\"(n)时无需填写;</br>是否进行预防效果评估(VTE-3-4-3)等于\"否\"(n)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"无症状性VTE的发生\"(a)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"与预防相关的不良事件\"(d)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"与预防不相关的不良事件\"(e)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"其他\"(oth)时无需填写;</br>是否为临床高度拟诊\"VTE\"的患者(VTE-4-1-1)等于\"非临床高度拟诊\"VTE\"的患者\"(c)时无需填写;</br>临床高度可疑为VTE后,针对性紧急处理的方法(VTE-4-2-2)等于\"无法确定或无记录\"(UTD)时无需填写;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"溶栓剂（rt-PA+尿激酶）治疗医嘱的执行起始的时间","submitName":"VTE-4-5-1-a","type":"字符串","example":"例:\"1970-01-01 12:00:00\"","notNull":"参考备注","remark":"是否需要三级预防深静脉栓塞(VTE-3-3-0)等于\"否\"(n)时无需填写;</br>是否进行预防效果评估(VTE-3-4-3)等于\"否\"(n)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"无症状性VTE的发生\"(a)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"与预防相关的不良事件\"(d)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"与预防不相关的不良事件\"(e)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"其他\"(oth)时无需填写;</br>是否为临床高度拟诊\"VTE\"的患者(VTE-4-1-1)等于\"非临床高度拟诊\"VTE\"的患者\"(c)时无需填写;</br>临床高度可疑为VTE后,针对性紧急处理的方法(VTE-4-2-2)等于\"无法确定或无记录\"(UTD)时无需填写;</br>抗凝重叠治疗医嘱的执行起始的时间选择(VTE-4-5-1)等于\"溶栓剂（rt-PA+尿激酶）治疗医嘱的执行起始的时间\"(a)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":null},{"title":"溶栓剂（rt-PA使用普通肝素（UFH）治疗医嘱的执行起始的时间+尿激酶）治疗医嘱的执行起始的时间","submitName":"VTE-4-5-1-b","type":"字符串","example":"例:\"1970-01-01 12:00:00\"","notNull":"参考备注","remark":"是否需要三级预防深静脉栓塞(VTE-3-3-0)等于\"否\"(n)时无需填写;</br>是否进行预防效果评估(VTE-3-4-3)等于\"否\"(n)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"无症状性VTE的发生\"(a)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"与预防相关的不良事件\"(d)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"与预防不相关的不良事件\"(e)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"其他\"(oth)时无需填写;</br>是否为临床高度拟诊\"VTE\"的患者(VTE-4-1-1)等于\"非临床高度拟诊\"VTE\"的患者\"(c)时无需填写;</br>临床高度可疑为VTE后,针对性紧急处理的方法(VTE-4-2-2)等于\"无法确定或无记录\"(UTD)时无需填写;</br>抗凝重叠治疗医嘱的执行起始的时间选择(VTE-4-5-1)等于\"使用普通肝素（UFH）治疗医嘱的执行起始的时间\"(b)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":null},{"title":"低分子肝素钙（LMWH）治疗医嘱的执行起始的时间","submitName":"VTE-4-5-1-c","type":"字符串","example":"例:\"1970-01-01 12:00:00\"","notNull":"参考备注","remark":"是否需要三级预防深静脉栓塞(VTE-3-3-0)等于\"否\"(n)时无需填写;</br>是否进行预防效果评估(VTE-3-4-3)等于\"否\"(n)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"无症状性VTE的发生\"(a)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"与预防相关的不良事件\"(d)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"与预防不相关的不良事件\"(e)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"其他\"(oth)时无需填写;</br>是否为临床高度拟诊\"VTE\"的患者(VTE-4-1-1)等于\"非临床高度拟诊\"VTE\"的患者\"(c)时无需填写;</br>临床高度可疑为VTE后,针对性紧急处理的方法(VTE-4-2-2)等于\"无法确定或无记录\"(UTD)时无需填写;</br>抗凝重叠治疗医嘱的执行起始的时间选择(VTE-4-5-1)等于\"低分子肝素钙（LMWH）治疗医嘱的执行起始的时间\"(c)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":null},{"title":"维生素K拮抗剂（VKA）治疗医嘱的执行起始的时间","submitName":"VTE-4-5-1-d","type":"字符串","example":"例:\"1970-01-01 12:00:00\"","notNull":"参考备注","remark":"是否需要三级预防深静脉栓塞(VTE-3-3-0)等于\"否\"(n)时无需填写;</br>是否进行预防效果评估(VTE-3-4-3)等于\"否\"(n)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"无症状性VTE的发生\"(a)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"与预防相关的不良事件\"(d)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"与预防不相关的不良事件\"(e)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"其他\"(oth)时无需填写;</br>是否为临床高度拟诊\"VTE\"的患者(VTE-4-1-1)等于\"非临床高度拟诊\"VTE\"的患者\"(c)时无需填写;</br>临床高度可疑为VTE后,针对性紧急处理的方法(VTE-4-2-2)等于\"无法确定或无记录\"(UTD)时无需填写;</br>抗凝重叠治疗医嘱的执行起始的时间选择(VTE-4-5-1)等于\"维生素K拮抗剂（VKA）治疗医嘱的执行起始的时间\"(d)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":null},{"title":"华法林（Warfarin）治疗医嘱的执行起始的时间","submitName":"VTE-4-5-1-e","type":"字符串","example":"例:\"1970-01-01 12:00:00\"","notNull":"参考备注","remark":"是否需要三级预防深静脉栓塞(VTE-3-3-0)等于\"否\"(n)时无需填写;</br>是否进行预防效果评估(VTE-3-4-3)等于\"否\"(n)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"无症状性VTE的发生\"(a)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"与预防相关的不良事件\"(d)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"与预防不相关的不良事件\"(e)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"其他\"(oth)时无需填写;</br>是否为临床高度拟诊\"VTE\"的患者(VTE-4-1-1)等于\"非临床高度拟诊\"VTE\"的患者\"(c)时无需填写;</br>临床高度可疑为VTE后,针对性紧急处理的方法(VTE-4-2-2)等于\"无法确定或无记录\"(UTD)时无需填写;</br>抗凝重叠治疗医嘱的执行起始的时间选择(VTE-4-5-1)等于\"华法林（Warfarin）治疗医嘱的执行起始的时间\"(e)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":null},{"title":"其他抗凝剂治疗医嘱的执行起始的时间","submitName":"VTE-4-5-1-f","type":"字符串","example":"例:\"1970-01-01 12:00:00\"","notNull":"参考备注","remark":"是否需要三级预防深静脉栓塞(VTE-3-3-0)等于\"否\"(n)时无需填写;</br>是否进行预防效果评估(VTE-3-4-3)等于\"否\"(n)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"无症状性VTE的发生\"(a)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"与预防相关的不良事件\"(d)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"与预防不相关的不良事件\"(e)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"其他\"(oth)时无需填写;</br>是否为临床高度拟诊\"VTE\"的患者(VTE-4-1-1)等于\"非临床高度拟诊\"VTE\"的患者\"(c)时无需填写;</br>临床高度可疑为VTE后,针对性紧急处理的方法(VTE-4-2-2)等于\"无法确定或无记录\"(UTD)时无需填写;</br>抗凝重叠治疗医嘱的执行起始的时间选择(VTE-4-5-1)等于\"其他抗凝剂治疗医嘱的执行起始的时间\"(f)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":null},{"title":"放置静脉滤器（IVCF）预防PTE的执行起始的时间","submitName":"VTE-4-6-1","type":"字符串","example":"例:\"1970-01-01 12:00\"","notNull":"参考备注","remark":"是否需要三级预防深静脉栓塞(VTE-3-3-0)等于\"否\"(n)时无需填写;</br>是否进行预防效果评估(VTE-3-4-3)等于\"否\"(n)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"无症状性VTE的发生\"(a)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"与预防相关的不良事件\"(d)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"与预防不相关的不良事件\"(e)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"其他\"(oth)时无需填写;</br>是否为临床高度拟诊\"VTE\"的患者(VTE-4-1-1)等于\"非临床高度拟诊\"VTE\"的患者\"(c)时无需填写;</br>临床高度可疑为VTE后,针对性紧急处理的方法(VTE-4-2-2)等于\"无法确定或无记录\"(UTD)时无需填写;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":null},{"title":"放置静脉滤器（IVCF）预防PTE的术式","submitName":"VTE-4-6-2","type":"字符串","example":"例:\"a\"","notNull":"参考备注","remark":"是否需要三级预防深静脉栓塞(VTE-3-3-0)等于\"否\"(n)时无需填写;</br>是否进行预防效果评估(VTE-3-4-3)等于\"否\"(n)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"无症状性VTE的发生\"(a)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"与预防相关的不良事件\"(d)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"与预防不相关的不良事件\"(e)时无需填写;</br>预防效果评估及相关不良事件(VTE-3-4-4)等于\"其他\"(oth)时无需填写;</br>是否为临床高度拟诊\"VTE\"的患者(VTE-4-1-1)等于\"非临床高度拟诊\"VTE\"的患者\"(c)时无需填写;</br>临床高度可疑为VTE后,针对性紧急处理的方法(VTE-4-2-2)等于\"无法确定或无记录\"(UTD)时无需填写;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"离院方式选择","submitName":"CM-4-3","type":"字符串","example":"例:\"a\"","notNull":"是","remark":"","hasTable":"true"},{"title":"非医嘱离院可能涉及因素","submitName":"CM-4-5","type":"数组","example":"例:[\"a\",\"b\"]","notNull":"参考备注","remark":"离院方式选择(CM-4-3)等于\"非医嘱离院\"(d)时可填写;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"其他非医嘱离院因素填写","submitName":"CM-4-4-1","type":"字符串","example":"例:\"填写文字说明\"","notNull":"参考备注","remark":"非医嘱离院可能涉及因素(CM-4-5)等于\"其他\"(oth)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":null},{"title":"死亡可能涉及因素","submitName":"CM-4-6","type":"字符串","example":"例:\"a\"","notNull":"参考备注","remark":"离院方式选择(CM-4-3)等于\"死亡\"(e)时可填写;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"患者是否对服务的体验与评价","submitName":"CM-5-1","type":"字符串","example":"例:\"y\"","notNull":"是","remark":"","hasTable":"true"},{"title":"整体医院评级","submitName":"CM-5-2-1","type":"字符串","example":"例:\"a\"","notNull":"参考备注","remark":"患者是否对服务的体验与评价(CM-5-1)等于\"是\"(y)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"患者推荐","submitName":"CM-5-2-2","type":"字符串","example":"例:\"a\"","notNull":"参考备注","remark":"患者是否对服务的体验与评价(CM-5-1)等于\"是\"(y)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"病房、床单元和卫生间清洁度","submitName":"CM-5-2-3","type":"字符串","example":"例:\"a\"","notNull":"参考备注","remark":"患者是否对服务的体验与评价(CM-5-1)等于\"是\"(y)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"病房与周边噪音","submitName":"CM-5-2-5","type":"字符串","example":"例:\"a\"","notNull":"参考备注","remark":"患者是否对服务的体验与评价(CM-5-1)等于\"是\"(y)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"医生沟通","submitName":"CM-5-2-6","type":"字符串","example":"例:\"a\"","notNull":"参考备注","remark":"患者是否对服务的体验与评价(CM-5-1)等于\"是\"(y)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"护士沟通","submitName":"CM-5-2-7","type":"字符串","example":"例:\"a\"","notNull":"参考备注","remark":"患者是否对服务的体验与评价(CM-5-1)等于\"是\"(y)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"药师沟通","submitName":"CM-5-2-8","type":"字符串","example":"例:\"a\"","notNull":"参考备注","remark":"患者是否对服务的体验与评价(CM-5-1)等于\"是\"(y)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"康复计划","submitName":"CM-5-2-9","type":"字符串","example":"例:\"a\"","notNull":"参考备注","remark":"患者是否对服务的体验与评价(CM-5-1)等于\"是\"(y)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"出院时的知情告知","submitName":"CM-5-2-10","type":"字符串","example":"例:\"a\"","notNull":"参考备注","remark":"患者是否对服务的体验与评价(CM-5-1)等于\"是\"(y)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"膳食评价","submitName":"CM-5-2-11","type":"字符串","example":"例:\"a\"","notNull":"参考备注","remark":"患者是否对服务的体验与评价(CM-5-1)等于\"是\"(y)时必填;</br>若该字段无相应取值，则接口中不必提交该字段</br>","hasTable":"true"},{"title":"住院总费用","submitName":"CM-6-1","type":"数值","example":"例:10","notNull":"是","remark":"住院总费用要大于0;</br>住院总费用要小于1000000;</br>住院总费用应大于等于各项费用之和","hasTable":null},{"title":"住院总费用其中自付金额","submitName":"CM-6-2","type":"数值","example":"例:10","notNull":"是","remark":"自付金额要‎≥0;</br>自付金额应≤住院总费用","hasTable":null},{"title":"一般医疗服务费","submitName":"CM-6-3","type":"数值","example":"例:10","notNull":"是","remark":"一般医疗服务费要‎≥0","hasTable":null},{"title":"一般治疗操作费","submitName":"CM-6-4","type":"数值","example":"例:10","notNull":"是","remark":"一般治疗操作费要‎≥0","hasTable":null},{"title":"护理费","submitName":"CM-6-5","type":"数值","example":"例:10","notNull":"是","remark":"护理费要‎≥0","hasTable":null},{"title":"综合医疗服务类其他费用","submitName":"CM-6-6","type":"数值","example":"例:10","notNull":"是","remark":"综合医疗服务类其他费用要≥0","hasTable":null},{"title":"病理诊断费","submitName":"CM-6-7","type":"数值","example":"例:10","notNull":"是","remark":"病理诊断费要≥0","hasTable":null},{"title":"实验室诊断费","submitName":"CM-6-8","type":"数值","example":"例:10","notNull":"是","remark":"实验室诊断费要≥0","hasTable":null},{"title":"影像学诊断费","submitName":"CM-6-9","type":"数值","example":"例:10","notNull":"是","remark":"影像学诊断费要≥0","hasTable":null},{"title":"临床诊断项目费","submitName":"CM-6-10","type":"数值","example":"例:10","notNull":"是","remark":"临床诊断项目费要≥0","hasTable":null},{"title":"非手术治疗项目费","submitName":"CM-6-11","type":"数值","example":"例:10","notNull":"是","remark":"非手术治疗项目费要≥0","hasTable":null},{"title":"其中：临床物理治疗费","submitName":"CM-6-12","type":"数值","example":"例:10","notNull":"是","remark":"临床物理治疗费要≥0","hasTable":null},{"title":"手术治疗费","submitName":"CM-6-13","type":"数值","example":"例:10","notNull":"是","remark":"手术治疗费要≥0","hasTable":null},{"title":"其中：麻醉费","submitName":"CM-6-14","type":"数值","example":"例:10","notNull":"是","remark":"麻醉费要≥0","hasTable":null},{"title":"其中：手术费","submitName":"CM-6-15","type":"数值","example":"例:10","notNull":"是","remark":"手术费要≥0","hasTable":null},{"title":"康复费","submitName":"CM-6-16","type":"数值","example":"例:10","notNull":"是","remark":"康复费要≥0","hasTable":null},{"title":"中医治疗费","submitName":"CM-6-17","type":"数值","example":"例:10","notNull":"是","remark":"中医治疗费要≥0","hasTable":null},{"title":"西药费","submitName":"CM-6-18","type":"数值","example":"例:10","notNull":"是","remark":"西药费要≥0","hasTable":null},{"title":"其中：抗菌药物费","submitName":"CM-6-19","type":"数值","example":"例:10","notNull":"是","remark":"抗菌药物费要≥0","hasTable":null},{"title":"中成药费","submitName":"CM-6-20","type":"数值","example":"例:10","notNull":"是","remark":"中成药费要≥0","hasTable":null},{"title":"中草药费","submitName":"CM-6-21","type":"数值","example":"例:10","notNull":"是","remark":"中草药费要≥0","hasTable":null},{"title":"血费","submitName":"CM-6-22","type":"数值","example":"例:10","notNull":"是","remark":"血费要≥0","hasTable":null},{"title":"白蛋白类制品费","submitName":"CM-6-23","type":"数值","example":"例:10","notNull":"是","remark":"白蛋白类制品费要≥0","hasTable":null},{"title":"球蛋白类制品费","submitName":"CM-6-24","type":"数值","example":"例:10","notNull":"是","remark":"球蛋白类制品费要≥0","hasTable":null},{"title":"凝血因子类制品费","submitName":"CM-6-25","type":"数值","example":"例:10","notNull":"是","remark":"凝血因子类制品费要≥0","hasTable":null},{"title":"细胞因子类制品费","submitName":"CM-6-26","type":"数值","example":"例:10","notNull":"是","remark":"细胞因子类制品费要≥0","hasTable":null},{"title":"检查用一次性医用材料费","submitName":"CM-6-27","type":"数值","example":"例:10","notNull":"是","remark":"检查用一次性医用材料费要≥0","hasTable":null},{"title":"治疗用一次性医用材料费","submitName":"CM-6-28","type":"数值","example":"例:10","notNull":"是","remark":"治疗用一次性医用材料费要≥0","hasTable":null},{"title":"手术用一次性医用材料费","submitName":"CM-6-29","type":"数值","example":"例:10","notNull":"是","remark":"手术用一次性医用材料费要≥0","hasTable":null},{"title":"其他费","submitName":"CM-6-30","type":"数值","example":"例:10","notNull":"是","remark":"其他费要≥0","hasTable":null}],"down":[{"title":"中高风险患者和入住ICU的患者的主要风险项选择","submitName":"VTE-0-1-1","list":[{"val":"def","remark":"请选择"},{"val":"a","remark":"高龄（≥70岁）"},{"val":"b","remark":"既往VTE病史或VTE家族史"},{"val":"c","remark":"恶性肿瘤"},{"val":"d","remark":"脓毒症"},{"val":"e","remark":"严重创伤"},{"val":"f","remark":"急性生理和慢性健康评分⁃Ⅱ"},{"val":"g","remark":"急诊手术及麻醉复苏室转入"},{"val":"h","remark":"转入ICU前住院时间长"},{"val":"i","remark":"制动"},{"val":"j","remark":"机械通气"},{"val":"k","remark":"留置中心静脉导管"},{"val":"l","remark":"血液净化治疗"},{"val":"m","remark":"使用肌肉松弛和镇静药物"},{"val":"n","remark":"应用收缩血管药物"},{"val":"o","remark":"输注血小板"},{"val":"p","remark":"血栓预防失败"},{"val":"q","remark":"医师认为需评估的其他中高风险患者--高危孕产妇"}]},{"title":"恶性肿瘤ICD-10类目编码","submitName":"VTE-0-1-1-c","list":[{"val":"def","remark":"请选择"},{"val":"a","remark":"C00-C97恶性肿瘤住院接受病损或组织手术切除治疗的患者"},{"val":"b","remark":"C00-C97恶性肿瘤住院接受根治性巴结清扫术的患者"},{"val":"c","remark":"C00-C97恶性肿瘤住院接受全身抗肿瘤治疗的患者"}]},{"title":"脓毒症ICD-10亚目编码","submitName":"VTE-0-1-1-d","list":[{"val":"def","remark":"请选择"},{"val":"d","remark":"A40.0 A族链球菌性脓毒病"},{"val":"e","remark":"A40.1 B族链球菌性脓毒病"},{"val":"f","remark":"A40.2 D族链球菌性脓毒病"},{"val":"g","remark":"A40.3 肺炎链球菌性脓毒病"},{"val":"h","remark":"A40.8 其他链球菌性脓毒病"},{"val":"i","remark":"A40.9 未特指的链球菌性脓毒病"},{"val":"j","remark":"A41.0 金黄色葡萄球菌性败血症"},{"val":"k","remark":"A41.1 其他特指的葡萄球菌性脓毒病"},{"val":"l","remark":"A41.2 未特指的葡萄球菌性脓毒病"},{"val":"m","remark":"A41.3 流感嗜血杆菌性脓毒病"},{"val":"n","remark":"A41.4 厌氧菌性脓毒病"},{"val":"o","remark":"A41.5 其他革兰氏阴性病原体性脓毒病"},{"val":"p","remark":"A41.8 其他特指的脓毒病"},{"val":"q","remark":"A41.9 未特指的脓毒病(感染性休克)"},{"val":"u","remark":"R65.2非传染性病因的全身炎症反应综合征不伴有器官衰竭"},{"val":"v","remark":"R65.3非传染性病因的全身炎症反应综合征伴有器官衰竭"},{"val":"w","remark":"R65.9未特指的全身炎症反应综合征"}]},{"title":"累及身体多个部位损伤ICD-10类目编码","submitName":"VTE-0-1-1-e","list":[{"val":"def","remark":"请选择"},{"val":"a","remark":"T01 累及身体多个部位的开放性伤口"},{"val":"b","remark":"T02 累及身体多个部位的骨折"},{"val":"c","remark":"T03 累及身体多个部位的脱位、扭伤和劳损"},{"val":"d","remark":"T04 累及身体多个部位的挤压伤"},{"val":"e","remark":"T05 累及身体多个部位的创伤性切断"},{"val":"f","remark":"T06 累及身体多个部位的其他损伤,不可归类在他处者"}]},{"title":"制动选择","submitName":"VTE-0-1-1-i","list":[{"val":"def","remark":"请选择"},{"val":"a","remark":"住院期间持续使用约束措施（≥4小时）"},{"val":"b","remark":"骨科骨牵引长期卧床（≥7天）"}]},{"title":"机械通气ICD-9-CM-3亚目编码","submitName":"VTE-0-1-1-j","list":[{"val":"def","remark":"请选择"},{"val":"a","remark":"93.90 无创机械性通气"},{"val":"b","remark":"93.91 间歇性正压通气[IPPB]"},{"val":"c","remark":"96.70 未特指时间的持续性侵入性机械通气"},{"val":"d","remark":"96.71 小于96小时连续的持续性侵入性机械通气"},{"val":"e","remark":"96.72 大于等于96小时连续的持续性侵入性机械通气"},{"val":"f","remark":"39.65 膜肺氧合ECMO"}]},{"title":"留置中心静脉导管ICD-9-CM-3亚目编码","submitName":"VTE-0-1-1-k","list":[{"val":"def","remark":"请选择"},{"val":"a","remark":"89.60 持续性动脉内血气监测"},{"val":"b","remark":"89.61 全身动脉压监测"},{"val":"c","remark":"89.62 中心静脉压监测"},{"val":"d","remark":"89.63 肺动脉压监测"},{"val":"e","remark":"89.64 肺动脉楔形监测"},{"val":"f","remark":"89.65 全身动脉血气测量"},{"val":"g","remark":"89.66 89.6600 混合静脉血气测量"},{"val":"h","remark":"89.67 心脏排出量监测，用氧耗技术"},{"val":"i","remark":"89.68 心脏排出量监测，其他技术"}]},{"title":"血液净化治疗ICD-9-CM-3亚目编码","submitName":"VTE-0-1-1-l","list":[{"val":"def","remark":"请选择"},{"val":"a","remark":"39.95血液透析"}]},{"title":"使用肌肉松弛和镇静药物选择","submitName":"VTE-0-1-1-m","list":[{"val":"def","remark":"请选择"},{"val":"a","remark":"肌肉松弛剂；氯羟苯恶唑；5-氯-2-羟基苯并恶唑；氯苯恶唑酮；氯羟苯恶唑；氯羟苯恶唑等"},{"val":"b","remark":"ICU常用的镇静药物主要为：苯二氮卓类：包括安定、咪达唑仑, 丙泊酚，右美托咪定等"}]},{"title":"应用收缩血管药物选择","submitName":"VTE-0-1-1-n","list":[{"val":"def","remark":"请选择"},{"val":"a","remark":"强效的缩血管药物,  主要包括去甲肾上腺素、肾上腺素和麻黄素等"},{"val":"b","remark":"中等强度的缩血管药物,  主要包括多巴胺、多巴酚丁胺等"},{"val":"c","remark":"非肾上腺素能缩血管药物，主要包括血管加压素等"}]},{"title":"医师认为需评估的其他中高风险患者--高危孕产妇记录","submitName":"VTE-0-1-1-q","list":[{"val":"def","remark":"请选择"},{"val":"a","remark":"子痫前期"},{"val":"b","remark":"多胎妊娠"},{"val":"c","remark":"妊娠期糖尿病"},{"val":"d","remark":"选择性剖宫产"},{"val":"e","remark":"产时剖宫产"},{"val":"f","remark":"子宫切除术"},{"val":"g","remark":"早产分娩"},{"val":"h","remark":"产后出血（≥1000ml/或需要輸血)"},{"val":"i","remark":"死胎"},{"val":"j","remark":"中位产钳"},{"val":"k","remark":"产程≥24小时"},{"val":"l","remark":"医师认为需评估的其他中高风险患者"}]},{"title":"是否出院后31天内重复住院","submitName":"CM-0-1-5","list":[{"val":"y","remark":"是"},{"val":"n","remark":"否"}]},{"title":"患者性别","submitName":"CM-0-2-1-2","list":[{"val":"M","remark":"男"},{"val":"F","remark":"女"}]},{"title":"费用支付方式","submitName":"CM-0-3-1","list":[{"val":"def","remark":"请选择"},{"val":"a","remark":"城镇职工基本医疗保险"},{"val":"b","remark":"城镇居民基本医疗保险"},{"val":"c","remark":"新型农村合作医疗"},{"val":"d","remark":"贫困救助"},{"val":"e","remark":"商业医疗保险"},{"val":"f","remark":"公费医疗"},{"val":"g","remark":"全自费"},{"val":"h","remark":"其他社会保险（ 生育保险、工伤保险、农民工保险等）"},{"val":"i","remark":"其他"}]},{"title":"收入住院途径","submitName":"CM-0-3-2","list":[{"val":"def","remark":"请选择"},{"val":"a","remark":"门诊"},{"val":"b","remark":"急诊"},{"val":"c","remark":"其他医疗机构转入"},{"val":"d","remark":"院内其他临床科室转入"},{"val":"e","remark":"其他"}]},{"title":"到院交通工具","submitName":"CM-0-3-3","list":[{"val":"def","remark":"请选择"},{"val":"a","remark":"救护车"},{"val":"b","remark":"出租车"},{"val":"c","remark":"私家车"},{"val":"d","remark":"其他"}]},{"title":"实施血栓风险因素评估工具选择","submitName":"VTE-1-1-1","list":[{"val":"def","remark":"请选择"},{"val":"a","remark":"手术患者静脉血栓栓塞症风险评估表（Caprini评分表）"},{"val":"b","remark":"内科住院患者静脉血栓栓塞症风险评估表（Padua评分表）"}]},{"title":"风险分层","submitName":"VTE-1-1-3","list":[{"val":"def","remark":"请选择"},{"val":"a","remark":"低危0-2分"},{"val":"b","remark":"中危3-4分"},{"val":"c","remark":"高危≥5分"}]},{"title":"风险分层","submitName":"VTE-1-1-5","list":[{"val":"def","remark":"请选择"},{"val":"a","remark":"低危0-3分"},{"val":"b","remark":"高危≥4分"}]},{"title":"实施实施下肢静脉血管多普勒超声检查评估","submitName":"VTE-2-1-1","list":[{"val":"y","remark":"实施"},{"val":"n","remark":"不实施"}]},{"title":"有无多普勒超声检查阳性发现","submitName":"VTE-2-1-3","list":[{"val":"y","remark":"有阳性发现"},{"val":"n","remark":"无阳性发现"}]},{"title":"实施D⁃二聚体检测评估","submitName":"VTE-2-2-1","list":[{"val":"y","remark":"实施"},{"val":"n","remark":"不实施"}]},{"title":"D⁃二聚体检测评估结论","submitName":"VTE-2-2-4","list":[{"val":"def","remark":"请选择"},{"val":"a","remark":"D⁃二聚体检测水平增高"},{"val":"b","remark":"定性阴性"}]},{"title":"是否实施氧合评估","submitName":"VTE-2-2-5","list":[{"val":"y","remark":"是"},{"val":"n","remark":"否"}]},{"title":"氧合评估","submitName":"VTE-2-2-6","list":[{"val":"def","remark":"请选择"},{"val":"a","remark":"动脉血气分析（PaO₂）"},{"val":"b","remark":"指氧仪检查（SatO₂）"}]},{"title":"是否实施心脏生物学标志物检测","submitName":"VTE-2-2-7","list":[{"val":"y","remark":"实施"},{"val":"n","remark":"不实施"}]},{"title":"心脏生物学标志物检测项目","submitName":"VTE-2-2-8","list":[{"val":"a","remark":"肌钙蛋白T（TnT）"},{"val":"b","remark":"肌钙蛋白I（TnI）"},{"val":"c","remark":"肌酸激酶同工酶（CK-MB）"},{"val":"d","remark":"心肌肌红蛋白（Myo）"},{"val":"e","remark":"B型钠尿肽（BNP）"},{"val":"f","remark":"N端B型钠尿肽前体（NT-ProBNP）"}]},{"title":"是否实施凝血功能检测","submitName":"VTE-2-2-9","list":[{"val":"y","remark":"实施"},{"val":"n","remark":"不实施"}]},{"title":"凝血功能检测项目","submitName":"VTE-2-2-10","list":[{"val":"a","remark":"血浆凝血酶原时间（PT）"},{"val":"b","remark":"纤维蛋白原（FIB）"},{"val":"c","remark":"活化部分凝血活酶时间（APTT）"},{"val":"d","remark":"血浆凝血酶时间（TT）"}]},{"title":"是否行CT肺动脉造影（CTPA）检查评估","submitName":"VTE-2-3-1","list":[{"val":"y","remark":"实施"},{"val":"n","remark":"不实施"}]},{"title":"CT肺动脉造影（CTPA）检查阳性发现","submitName":"VTE-2-3-3","list":[{"val":"y","remark":"有阳性发现"},{"val":"n","remark":"无阳性发现"}]},{"title":"有无履行VTE预防相关的患者/家属知情同意","submitName":"VTE-3-1-1","list":[{"val":"y","remark":"是"},{"val":"n","remark":"否"}]},{"title":"VTE预防相关的患者/家属知情同意","submitName":"VTE-3-1-2","list":[{"val":"a","remark":"住院患者常存在发生DVT-PTE甚至死亡的风险，也可能由此引起血栓栓综合征（PTS1.慢性血栓栓塞性肺高压（CTEPH）或复发性VTE而致残"},{"val":"b","remark":"进行有效预防可以明显降低上述风险，对大多数VTE高危患者是安全的"},{"val":"c","remark":"VTE的预防措施存在着一些不可预期的风险，包括皮下出血和淤血;手术部位和切口出血;肝素诱导的血小板减少（HIT）;脑出血和消化道出血，甚至导致死亡"},{"val":"d","remark":"即使采取有效的药物和物理预防措施，仍不能完全杜绝VTE的发生"},{"val":"e","remark":"临床医师记录有其他禁忌症,不适宜实施药物预防"}]},{"title":"有无实施出血风险和其他可能影响预防的因素评估","submitName":"VTE-3-2-1","list":[{"val":"y","remark":"是，有禁忌"},{"val":"n","remark":"否，无禁忌"}]},{"title":"实施出血风险和其他可能影响预防的因素评估","submitName":"VTE-3-2-2","list":[{"val":"a","remark":"患者因素"},{"val":"b","remark":"基础疾病"},{"val":"c","remark":"合并用药"},{"val":"d","remark":"侵入性操作"},{"val":"oth","remark":"其他"}]},{"title":"患者因素选择","submitName":"VTE-3-2-2-1","list":[{"val":"a","remark":"年龄≥75岁"},{"val":"b","remark":"凝血功能障碍"},{"val":"c","remark":"血小板< 50×l0^9/L"}]},{"title":"基础疾病","submitName":"VTE-3-2-2-2","list":[{"val":"a","remark":"活动性出血，如未控制的消化性溃疡、出血性疾病或出血等"},{"val":"b","remark":"既往颅内出血史或其他大出血史"},{"val":"c","remark":"未控制的高血压，收缩压>180 mmHg或舒张压> 110 mmHg(l mmHg=0.133 kPa)"},{"val":"d","remark":"可能导致严重出血的颅内疾病，如急性脑卒中（3个月内），严重颅脑或急性脊髓损伤"},{"val":"e","remark":"糖尿病"},{"val":"f","remark":"恶性肿瘤"},{"val":"g","remark":"严重的肾功能衰竭或肝功能衰竭等"}]},{"title":"合并用药","submitName":"VTE-3-2-2-3","list":[{"val":"a","remark":"正在使用抗凝药物、抗血小板药物或溶栓药物等"}]},{"title":"侵入性操作","submitName":"VTE-3-2-2-4","list":[{"val":"a","remark":"接受手术、腰穿和硬膜外麻醉之前4h和之后12h等"},{"val":"b","remark":"临床医师记录有其他禁忌症,不适宜实施药物预防"}]},{"title":"物理性预防措施应用禁忌","submitName":"VTE-3-2-3","list":[{"val":"a","remark":"充血性心力衰竭、肺水肿或下肢严重水肿"},{"val":"b","remark":"下肢VTE形成、肺栓塞发生或血栓（性）静脉炎"},{"val":"c","remark":"间歇充气加压装置及梯度压力弹力袜不适用于下肢局部异常"},{"val":"d","remark":"下肢血管严重动脉硬化或狭窄、其他缺血性血管病（糖尿病性等）及下肢严重畸形等"},{"val":"e","remark":"临床医师记录有其他禁忌症,不适宜实施物理预防措施"},{"val":"f","remark":"无物理性预防措施应用禁忌症"}]},{"title":"是否需要三级预防深静脉栓塞","submitName":"VTE-3-3-0","list":[{"val":"y","remark":"是"},{"val":"n","remark":"否"}]},{"title":"三级预防深静脉栓塞措施选择","submitName":"VTE-3-3-1","list":[{"val":"a","remark":"基本预防"},{"val":"b","remark":"机械预防"},{"val":"c","remark":"药物预防"},{"val":"d","remark":"药物预防+机械预防"}]},{"title":"基本预防措施的选择","submitName":"VTE-3-3-2","list":[{"val":"a","remark":"术后抬高患肢"},{"val":"b","remark":"尽早肢体、足、趾的主动与被动活动"},{"val":"c","remark":"离床活动，穿弹力袜"},{"val":"oth","remark":"其他"}]},{"title":"机械预防措施的选择","submitName":"VTE-3-3-4","list":[{"val":"a","remark":"静脉足泵"},{"val":"b","remark":"间歇充气加压装置"},{"val":"c","remark":"压力梯度长袜"},{"val":"oth","remark":"其他"}]},{"title":"预防性地药物的选择","submitName":"VTE-3-3-6","list":[{"val":"a","remark":"华法林"},{"val":"b","remark":"普通肝素"},{"val":"c","remark":"低分子肝素"},{"val":"d","remark":"达比加群"},{"val":"e","remark":"利伐沙班"},{"val":"f","remark":"阿哌沙班"},{"val":"oth","remark":"其他"}]},{"title":"出院后继续使用抗凝药","submitName":"VTE-3-3-8","list":[{"val":"def","remark":"请选择"},{"val":"a","remark":"华法林"},{"val":"b","remark":"普通肝素"},{"val":"c","remark":"低分子肝素"},{"val":"d","remark":"达比加群"},{"val":"e","remark":"利伐沙班"},{"val":"f","remark":"阿哌沙班"},{"val":"oth","remark":"其他"},{"val":"UTD","remark":"无法确定或无出院带药记录"}]},{"title":"预防依从性评估","submitName":"VTE-3-4-1","list":[{"val":"def","remark":"请选择"},{"val":"a","remark":"本例预防措施符合本院发布的《医院内VTE预防实施的时机、方案、方法、剂量、疗程》等官方文件"},{"val":"b","remark":"本例预防措施大部分符合本院发布的《医院内VTE预防实施的时机、方案、方法、剂量、疗程》等官方文件"},{"val":"c","remark":"本例预防措施少部分符合本院发布的《医院内VTE预防实施的时机、方案、方法、剂量、疗程》等官方文件"},{"val":"d","remark":"本院无《医院内VTE预防实施的时机、方案、方法、剂量、疗程等》等官方文件"}]},{"title":"预防安全性主要监测项目","submitName":"VTE-3-4-2","list":[{"val":"a","remark":"出血"},{"val":"b","remark":"过敏反应"},{"val":"c","remark":"肝功能"},{"val":"d","remark":"肾功能"},{"val":"e","remark":"血红蛋白"},{"val":"f","remark":"血小板"},{"val":"g","remark":"肢体变化"},{"val":"oth","remark":"其他"}]},{"title":"是否进行预防效果评估","submitName":"VTE-3-4-3","list":[{"val":"y","remark":"是"},{"val":"n","remark":"否"}]},{"title":"预防效果评估及相关不良事件","submitName":"VTE-3-4-4","list":[{"val":"a","remark":"无症状性VTE的发生"},{"val":"b","remark":"发生症状性VTE"},{"val":"c","remark":"发生致死性PTE"},{"val":"d","remark":"与预防相关的不良事件"},{"val":"e","remark":"与预防不相关的不良事件"},{"val":"oth","remark":"其他"}]},{"title":"是否为临床高度拟诊\"VTE\"的患者","submitName":"VTE-4-1-1","list":[{"val":"def","remark":"请选择"},{"val":"a","remark":"DVT临床高度可疑患者"},{"val":"b","remark":"急性PTE临床高度可疑患者"},{"val":"c","remark":"非临床高度拟诊\"VTE\"的患者"}]},{"title":"DVT临床高度可疑患者的识别检查项目","submitName":"VTE-4-1-2","list":[{"val":"a","remark":"血浆D-2聚体检查"},{"val":"b","remark":"下肢静脉加压超声检查"},{"val":"oth","remark":"其他识别方法"},{"val":"UTD","remark":"无法确定或无记录"}]},{"title":"急性PTE临床高度可疑患者的识别检查项目","submitName":"VTE-4-1-3","list":[{"val":"a","remark":"血浆D-二聚体检查"},{"val":"b","remark":"胸片"},{"val":"c","remark":"心电图"},{"val":"d","remark":"血气分析"},{"val":"e","remark":"床旁超声心动图"},{"val":"f","remark":"床旁经食管心脏超声"},{"val":"g","remark":"CT肺动脉造影( CTPA)"},{"val":"h","remark":"核素肺通气／灌注(A/Q)显像等检"},{"val":"oth","remark":"其他识别方法"},{"val":"UTD","remark":"无法确定或无记录"}]},{"title":"是否经MDT制定VTE 针对性紧急处理方案","submitName":"VTE-4-2-1","list":[{"val":"y","remark":"是"},{"val":"n","remark":"否"}]},{"title":"临床高度可疑为VTE后,针对性紧急处理的方法","submitName":"VTE-4-2-2","list":[{"val":"a","remark":"抗凝重叠治疗预防VTE 和PTE 进一步发展"},{"val":"b","remark":"溶栓治疗,可根据病情选择经导管溶栓或经外周静脉溶栓治疗"},{"val":"c","remark":"放置下腔静脉滤器（IVCF）预防PTE"},{"val":"d","remark":"机械粉碎或血栓抽吸"},{"val":"e","remark":"手术清除血栓"},{"val":"oth","remark":"其他"},{"val":"UTD","remark":"无法确定或无记录"}]},{"title":"抗凝重叠治疗医嘱的执行起始的时间选择","submitName":"VTE-4-5-1","list":[{"val":"a","remark":"溶栓剂（rt-PA+尿激酶）治疗医嘱的执行起始的时间"},{"val":"b","remark":"使用普通肝素（UFH）治疗医嘱的执行起始的时间"},{"val":"c","remark":"低分子肝素钙（LMWH）治疗医嘱的执行起始的时间"},{"val":"d","remark":"维生素K拮抗剂（VKA）治疗医嘱的执行起始的时间"},{"val":"e","remark":"华法林（Warfarin）治疗医嘱的执行起始的时间"},{"val":"f","remark":"其他抗凝剂治疗医嘱的执行起始的时间"}]},{"title":"放置静脉滤器（IVCF）预防PTE的术式","submitName":"VTE-4-6-2","list":[{"val":"def","remark":"请选择"},{"val":"a","remark":"38.7x03 上腔静脉滤器置入术"},{"val":"b","remark":"38.7x04 下腔静脉滤器置入术"},{"val":"c","remark":"38.8900x001 下肢静脉滤器置入术"}]},{"title":"离院方式选择","submitName":"CM-4-3","list":[{"val":"def","remark":"请选择"},{"val":"a","remark":"医嘱离院"},{"val":"b","remark":"医嘱转院"},{"val":"c","remark":"医嘱转社区卫生服务机构/乡镇卫生院"},{"val":"d","remark":"非医嘱离院"},{"val":"e","remark":"死亡"},{"val":"oth","remark":"其他方式离院"}]},{"title":"非医嘱离院可能涉及因素","submitName":"CM-4-5","list":[{"val":"a","remark":"经济原因"},{"val":"b","remark":"医疗保险付费方式原因"},{"val":"c","remark":"患者/家人要求原因"},{"val":"d","remark":"医院技术原因"},{"val":"e","remark":"医院环境原因"},{"val":"f","remark":"媒体资讯原因"},{"val":"oth","remark":"其他"},{"val":"UTD","remark":"无法确定或无记录"}]},{"title":"死亡可能涉及因素","submitName":"CM-4-6","list":[{"val":"def","remark":"请选择"},{"val":"a","remark":"死亡与VTE有直接关系"},{"val":"b","remark":"死亡与VTE有间接关系"},{"val":"c","remark":"死亡与VTE无关，即死于不相关的疾病，如癌症或其他意外"},{"val":"d","remark":"死亡，不知是否与VTE有关"}]},{"title":"患者是否对服务的体验与评价","submitName":"CM-5-1","list":[{"val":"y","remark":"是"},{"val":"n","remark":"否"}]},{"title":"整体医院评级","submitName":"CM-5-2-1","list":[{"val":"def","remark":"请选择"},{"val":"a","remark":"患者给医院整体评分9或10分"},{"val":"b","remark":"患者给医院整体评分7或8分"},{"val":"c","remark":"患者给医院整体评分6分及以下"}]},{"title":"患者推荐","submitName":"CM-5-2-2","list":[{"val":"def","remark":"请选择"},{"val":"a","remark":"说是的患者，他们肯定会给家人和朋友推荐这家医院"},{"val":"b","remark":"说是的患者，他们可能会给家人和朋友推荐这家医院"},{"val":"c","remark":"说不的患者，他们可能或肯定不会给家人和朋友推荐这家医院"}]},{"title":"病房、床单元和卫生间清洁度","submitName":"CM-5-2-3","list":[{"val":"def","remark":"请选择"},{"val":"a","remark":"患者说他们的房间和浴室“总是”干净"},{"val":"b","remark":"患者说他们的房间和浴室“经常”干净"},{"val":"c","remark":"患者说他们的房间和浴室“有时”或“从不”干净"}]},{"title":"病房与周边噪音","submitName":"CM-5-2-5","list":[{"val":"def","remark":"请选择"},{"val":"a","remark":"患者说他们房间周边在晚上“总是”安静"},{"val":"b","remark":"患者说他们房间周边在晚上“经常”安静"},{"val":"c","remark":"患者说他们房间周边在晚上“有时”或“从不”安静"}]},{"title":"医生沟通","submitName":"CM-5-2-6","list":[{"val":"def","remark":"请选择"},{"val":"a","remark":"患者说他们的医生“总是”很好沟通"},{"val":"b","remark":"患者说他们的医生“经常”很好沟通"},{"val":"c","remark":"患者说他们的医生“有时”或“从不”很好沟通"}]},{"title":"护士沟通","submitName":"CM-5-2-7","list":[{"val":"def","remark":"请选择"},{"val":"a","remark":"患者说他们的护士“总是”很好沟通"},{"val":"b","remark":"患者说他们的护士“经常”很好沟通"},{"val":"c","remark":"患者说他们的护士“有时”或“从不”很好沟通"}]},{"title":"药师沟通","submitName":"CM-5-2-8","list":[{"val":"def","remark":"请选择"},{"val":"a","remark":"患者说医院员工在给药前“总是”进行药品说明"},{"val":"b","remark":"患者说医院员工在给药前“经常”进行药品说明"},{"val":"c","remark":"患者说医院员工在给药前“有时”或“从不”进行药品说明"}]},{"title":"康复计划","submitName":"CM-5-2-9","list":[{"val":"def","remark":"请选择"},{"val":"a","remark":"患者说医生护士已经提供了出院后在家康复期间应该做什么的信息"},{"val":"b","remark":"患者说医生护士说了出院后要在家做康复，但没有理解应该具体如何做"},{"val":"c","remark":"患者说医生护士没有提供出院后在家康复期间应该做什么的信息"}]},{"title":"出院时的知情告知","submitName":"CM-5-2-10","list":[{"val":"def","remark":"请选择"},{"val":"a","remark":"患者强烈同意医生护士在离院时理解了他们的知情告知"},{"val":"b","remark":"患者同意医生护士在离院时理解了他们的知情告知"},{"val":"c","remark":"患者在离院时不理解医生护士的知情告知"}]},{"title":"膳食评价","submitName":"CM-5-2-11","list":[{"val":"def","remark":"请选择"},{"val":"a","remark":"患者给医院膳食评分9或10分"},{"val":"b","remark":"患者给医院膳食评分7或8分"},{"val":"c","remark":"患者给医院膳食评分6分及以下"}]}]},"error":null,"message":null,"exception":null,"result":null}